Vikram Solar contracts 1 GW of domestic cells from Avaada for ≈₹1,250 Cr, ahead of its own 9 GW plant

Vikram Solar told the exchanges after Tuesday's close that it has signed a domestic solar-cell supply agreement with Avaada Electro Limited: Avaada will supply 1 GW of ALMM-compliant, domestically manufactured half-cut N-Type G12R TOPCon solar cells for Vikram Solar's module manufacturing operations, in an agreement the filing sizes at approximately ₹1,250 crore, with deliveries scheduled to commence in September 2026. The first session in which the news could trade — September 16 — closed at ₹162.69, down 0.5%.

The distinction matters for how the ₹1,250 crore should be read. It is a purchase commitment, not revenue — cells are the input Vikram Solar's module lines consume. At roughly 21% of the company's ₹5,895 crore market cap it is a large one, and the press release presents it as supply-chain construction rather than a one-off: it "adds to the supply agreements the company has entered into earlier this year," and it complements the backward-integration plan under which the company's own 9 GW high-efficiency cell facility is scheduled to commission in Q4 FY27. Until that plant is running, agreements like this one are how the company sources domestically manufactured cells for the DCR segment it says it is targeting.

The pact extends a sequence of build-out disclosures. On August 6 the board approved, alongside Q1 FY27 results, the enhancement of the company's proposed backward-integrated wafer and ingot manufacturing facility at its Gangaikondan site in Tamil Nadu from 6 GW to 9 GW. On August 26 the company completed the acquisition of the entire shareholding of Vikram Solar Australia Pty Ltd, making it a wholly owned subsidiary. The Avaada agreement slots into that pattern: capacity and supply arrangements being assembled while the flagship cell plant is still under construction.

The market's first read of the agreement was close to flat: −0.5% on September 16. The bigger price event of the window remains the Q1 FY27 results, filed after close on August 6 — the stock fell 5.5% the next session, and the 52-week adjusted low of ₹155.38 is dated August 7, with the lowest close of the window (₹156.80) coming on August 10. The sharpest single-day move — August 17, up 14.3% on 6.51 crore shares, the heaviest volume of the period — fell in a gap in the company's disclosure record, with no filing between August 13 and August 26. At ₹162.69, the stock stands 55.5% below its 52-week adjusted high of ₹365.8, set on September 16, 2025, and 4.7% above the 52-week low.

This is the backdrop the ₹1,250 crore commitment lands on. Q1 FY27 consolidated revenue rose 37.9% year-on-year to ₹1,563.1 crore, but net profit fell 85.2% to ₹19.8 crore, with operating margin at 8.06% against 21.36% in Q1 FY26 and interest cost at ₹49.4 crore versus ₹32.3 crore a year earlier. The filings do not state the per-watt pricing or margin terms of the Avaada agreement, so its effect on cost of goods is not knowable from the disclosure — what can be said is that a procurement pact of this size is a cost-side commitment made in a quarter of sharply compressed profitability, and the company is betting that locked-in domestic cell supply supports the DCR volumes it is pursuing.